 | |
| Clinical data | |
|---|---|
| Other names | 2-(2-Pyrrolyl)ethylamine; NEA; 2-NEA |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C6H10N2 |
| Molar mass | 110.160 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2-Pyrrolylethylamine (NEA,2-NEA, or2-(2-pyrrolyl)ethylamine) is achemical compound of thearylalkylamine family.[1]
It is related to other arylalkylamines as well astrace amines includingtryptamine (2-indolylethylamine),phenethylamine (2-phenylethylamine),2-furylethylamine,thiopropamine (1-(2-thienyl)-2-aminopropane), andisocyclamine (cyclopentanylaminopropane), among others.[1] Many of these compounds aremonoamine releasing agents and/orreuptake inhibitors.[1]
NEA is known to bepharmacologically active itself, for instance havinghistamine-like activity on the isolatedguinea pigileum and having effects ongastric acidsecretion in dogs.[1]
The compound was first described in thescientific literature by 1949.[1]
 | Thispharmacology-related article is astub. You can help Wikipedia byexpanding it. |
